First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the target of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 21,717 shares, a growth of 169.2% from the June 30th total of 8,067 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily volume of 43,175 shares, the days-to-cover ratio is presently 0.5 days.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

First Trust NYSE Arca Biotechnology Index Fund stock traded down $0.03 during midday trading on Wednesday, hitting $251.28. 5,151 shares of the stock were exchanged, compared to its average volume of 125,917. First Trust NYSE Arca Biotechnology Index Fund has a 1 year low of $161.30 and a 1 year high of $258.20. The firm has a market cap of $2.85 billion, a P/E ratio of 21.72 and a beta of 0.65. The company has a 50 day moving average price of $235.49 and a two-hundred day moving average price of $216.72.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several large investors have recently modified their holdings of FBT. Private Trust Co. NA grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 290.9% during the 4th quarter. Private Trust Co. NA now owns 301 shares of the company’s stock valued at $62,000 after purchasing an additional 224 shares in the last quarter. Morey & Quinn Wealth Partners LLC raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 2.2% in the 4th quarter. Morey & Quinn Wealth Partners LLC now owns 3,391 shares of the company’s stock valued at $700,000 after purchasing an additional 73 shares in the last quarter. Fortis Capital Advisors LLC purchased a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at approximately $287,000. Sather Financial Group Inc purchased a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at approximately $207,000. Finally, HBW Advisory Services LLC purchased a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at approximately $519,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.